Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
|Videos|September 28, 2017
It's Not 'Just A Uterine Fibroid'
Author(s)Lauren Santye, Assistant Editor
In part 1 of 2, Beth Wallace shares her journey leading up to her diagnosis with leiomyosarcoma.
Advertisement
In part 1 of 2, Beth Wallace shares her journey leading up to her diagnosis with leiomyosarcoma.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Pharmacy Times
1
After 180 Years, Multiple Myeloma Gets a Definition of Cure
2
Psilocybin-Assisted Therapy for AUD: Emerging Evidence, Clinical and Cost Implications, and Treatment Gaps
3
Severe Asthma's Effects May Extend Beyond the Lungs, Brain Imaging Study Suggests
4
Armored CAR T-Cell Therapy Produces Durable Complete Response in Pediatric Solid Tumors
5